Search Clinical Pathways
Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Guidelines for evaluating patients suspected to have exocrine pancreatic insufficiency and initiating/optimizing pancreatic enzyme replacement therapy.
Inflammatory Bowel Disease with Iron Deficiency and Anemia Clinical Pathway — All Settings
Clinical Care Pathway for screening, management and follow up of iron deficiency and anemia among patients with Inflammatory Bowel Disease.
Preseptal or Orbital Cellulitis Clinical Pathway — All Settings
Inpatient and outpatient medical and surgical management for pediatric preseptal or orbital cellulitis patients
Infant Malnutrition Clinical Pathway — Outpatient Specialty Care and Primary Care
The Infant Malnutrition (Failure to Thrive) Pathway provides a consistent approach to caring for infants at risk for malnutrition in the outpatient setting.
Neonates with Hyperbilirubinemia/Jaundice Clinical Pathway
The hyperbilirubinemia pathway is a standard approach to initial evaluation, treatment, and management of infants with hyperbilirubinemia from birth through 21 days of life.
BMI-based Evaluation and Management in Children Clinical Pathway — Outpatient Specialty Care and Primary Care
The BMI-based evaluation and management clinical pathway is a task-oriented care plan that details essential steps in promoting weight management.
Mpox (Monkeypox) Clinical Pathway — Emergency Department, Outpatient Specialty Care and Primary Care
This pathway should be used to guide the health screening, evaluation and management of patients presenting with concerns for the mpox virus.
Fever Clinical Pathway — All Settings
The clinical pathway for child with fever guides early identification, evaluation and management of patients with high-risk factors or severe signs/symptoms of disease.
COVID-19 Screening Clinical Pathway — Outpatient Specialty Care and Primary Care
The Outpatient Specialty Care and Primary Care Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.
Active COVID-19, Clinical Pathway — All Settings
Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.